Resmetirom in the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Comprehensive Review of Current Evidence and Therapeutic Potential.

Saved in:
Bibliographic Details
Title: Resmetirom in the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Comprehensive Review of Current Evidence and Therapeutic Potential.
Authors: Patel RH; Internal Medicine, St. Mary Medical Center, Langhorne, USA., Parikh C; Internal Medicine, Mercy Catholic Medical Center, Philadelphia, USA., Upadhyay H; Respiratory Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, GBR., Sonaiya S; Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, USA., Ramnath P; Medical School, Jonelta Foundation School of Medicine, Manila, PHL., Singh S; Medicine, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR., Patel U; Internal Medicine, St. Mary Medical Center, Langhorne, USA., Kothari T; Gastroenterology, University of Rochester, Rochester, USA.
Source: Cureus [Cureus] 2024 Nov 29; Vol. 16 (11), pp. e74772. Date of Electronic Publication: 2024 Nov 29 (Print Publication: 2024).
Publication Type: Journal Article; Review
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.74772